Form 4: Eastman Chemical Co Director Renee J. Hornbaker Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Renee J. Hornbaker reports acquisition of phantom stock units through deferral of director's fees and reinvestment of dividend equivalents.
Summary
- Renee J. Hornbaker, a director of Eastman Chemical Co, filed a Form 4 indicating changes in beneficial ownership.
- The report details the acquisition of 277 phantom stock units on October 7, 2024, through the Directors' Deferred Compensation Plan.
- These units represent deferred director's fees that would have otherwise been paid in cash.
- The report also notes that Hornbaker beneficially owns 46,331 derivative securities, which includes 677 units credited since April 5, 2024, as hypothetical reinvestment of dividend equivalents.
- The phantom stock units have a value equal to one share of Eastman Chemical Co common stock and are payable only in cash after termination of service as a director.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, indicating a neutral to slightly positive sentiment due to alignment of interests.
Positives
- The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.
- Reinvestment of dividend equivalents demonstrates a commitment to increasing holdings in the company.
Industry Context
Directors' deferred compensation plans are a common practice in publicly traded companies to align the interests of directors with shareholders.
Comparison to Industry Standards
- Deferred compensation plans for directors are widely used among S&P 500 companies.
- The specifics of these plans, such as the types of securities offered and the payout terms, can vary significantly.
- Companies like Dow and DuPont also utilize similar deferred compensation structures for their board members.
Stakeholder Impact
- The transaction aligns the director's interests with shareholders, potentially fostering better corporate governance.
Key Dates
| Date | Description |
|---|---|
| 04/05/2024 | Start date for dividend equivalent reinvestment, resulting in 677 units credited. |
| 10/07/2024 | Date of transaction: Acquisition of 277 phantom stock units. |
| 10/09/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.